This simple test could detect Alzheimer’s before symptoms appear
Professor Ellen Grober, of Albert Einstein College of Medicine in New York, said: “This could be helpful in determining who to enroll in clinical trials for prevention of cognitive decline."
A simple memory test could pick up the early signs of Alzheimer’s before symptoms start to show, scientists discovered.
Having a poor score on a simple memory test may be linked to biomarkers in the brain connected with the cognitive disease, and thus could detect Alzheimer’s before symptoms, new research found.
The test could indicate the very early signs of memory impairment that precedes dementia by several years, experts said.
As part of the test, participants were shown pictures of items and given cues about their category, such as a picture of grapes with the prompt of “fruit."
They were then asked to remember the items, first on their own, then with the category cues for any items they did not remember.
Half of the participants had no memory problems, while half had issues with either memory retrieval, the storage of memories or both, scientists said.
Professor Ellen Grober, of Albert Einstein College of Medicine in the Bronx, New York, and the study author, said: “These findings suggest that this test can be used to improve our ability to detect cognitive decline in the stage before people are diagnosed with Alzheimer’s disease.
“This could be helpful in determining who to enroll in clinical trials for prevention of cognitive decline.
“It could also help by narrowing down those who already have signs of Alzheimer’s in the brain with a simple test rather than expensive or invasive scans or lumbar punctures.”
Diagnosing Alzheimer's before symptoms occur is crucial in developing treatments to fight cognitive decline (ESB Professional/Shutterstock)
This type of "controlled learning" helps with the mild memory retrieval problems that occur in many healthy elderly people but does not have much impact on memory for people with dementia, Prof Grober added.
The study involved 4,484 people with no cognitive problems and an average age of 71.
Participants were divided into five groups based on their scores on the test, or stages zero through four.
Stages zero through two reflect increasing difficulty with retrieving memories or items learned and precede dementia by five to eight years.
In these stages, people have increasing trouble remembering the items on their own, but they continue to be able to remember items when given cues.
During the third and fourth stages, people cannot remember all of the items even after they are given cues. These stages precede dementia by one to three years.
Prof Grober said: “This system allows us to distinguish between the following: the difficulty people have retrieving memories when they are still able to create and store memories in their brains, which occurs in the very early stages before dementia can be diagnosed; and the memory storage problems that occur later in this predementia phase when people can no longer store the memories in their brains.”
Study participants also had brain scans to look for the beta-amyloid plaques in the brain that are markers of Alzheimer’s disease, as well as to measure the volume of areas of the brain associated with Alzheimer’s pathology.
Researchers found people who tested in the third and fourth stages were likely to have higher amounts of beta-amyloid in their brains than people in the lower stages.
They were also more likely to have a lower volume in the hippocampus and other areas of the brain associated with Alzheimer’s pathology.
At stage zero, 30 percent of people had beta-amyloid plaques, compared to 31 percent at stage one, 35 percent at stage two, 40 percent at stage three and 44 percent at stage four.
A limitation of the study was that the participants had a high level of education, so the results may not be applicable to the general population, the authors added.
The study was published in the online issue of Neurology, the medical journal of the American Academy of Neurology.
The study was supported by the National Institutes of Health, Alzheimer’s Association, Cure Alzheimer Fund and Leonard and Sylvia Marx Foundation using publicly available data from the A4 study.
Stories and infographics by ‘Talker Research’ are available to download & ready to use. Stories and videos by ‘Talker News’ are managed by SWNS. To license content for editorial or commercial use and to see the full scope of SWNS content, please email [email protected] or submit an inquiry via our contact form.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.